Centiva Capital’s Cross Country Healthcare CCRN Stock Holding History

Centiva Capital’s Portfolio CCRN Stock Details CCRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$401K	Sell	42,642 -17,558	-29%	-$157K	﹤0.01%	941
2025 Q4	$488K	Buy	60,200 +30,200	+101%	+$330K	﹤0.01%	724
2025 Q3	$426K	Buy	+30,000	New	+$396K	﹤0.01%	683
2024 Q4	–	Sell	-43,017	Closed	-$578K	–	1753
2024 Q3	$578K	Buy	43,017 +14,466	+51%	+$213K	0.01%	1155
2024 Q2	$395K	Sell	28,551 -4,819	-14%	-$76.3K	0.01%	1303
2024 Q1	$625K	Buy	33,370 +14,858	+80%	+$297K	0.02%	892
2023 Q4	$419K	Buy	18,512 +1,033	+6%	+$22.4K	0.01%	1039
2023 Q3	$433K	Buy	+17,479	New	+$440K	0.01%	1020

Other funds holding CCRN

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

OBAM

ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return

DIA

Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return

Centiva Capital's CCRN Position: Q1 2026 in Review

Centiva Capital reduced its Cross Country Healthcare (CCRN) stake by 29% in Q1 2026, selling an estimated $157K and leaving 42,642 shares worth $401K. The position accounts for ﹤0.01% of the portfolio, ranked #941.

Centiva Capital first reported a position in CCRN in Q3 2023 and has held it in 8 quarters since. The position peaked at $625K in Q1 2024. 151 funds tracked by Wall St. Rank hold CCRN as of Q1 2026.

Centiva Capital held 42,642 shares of Cross Country Healthcare worth $401K as of Q1 2026.
Centiva Capital sold 17,558 Cross Country Healthcare shares in Q1 2026, an estimated $157K.
Cross Country Healthcare made up ﹤0.01% of Centiva Capital's portfolio in Q1 2026, its #941 holding.
Centiva Capital first reported a position in Cross Country Healthcare in Q3 2023 and has held it in 8 quarters since.
Centiva Capital's Cross Country Healthcare position peaked at $625K in Q1 2024.
151 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2026.

Based on Centiva Capital's 13F filing for Q1 2026, filed 14 May 2026.